Table 1 Summary of patient characteristics and response to toceranib
Patient | Breed | Treatment of Measurable Disease or Metastatic Disease | Response | PFI (weeks) | Reason for Toceranib Discontinuation | Alive? |
|---|---|---|---|---|---|---|
1 | Shih Tzu | Measurable | SD | 36 | Diarrhea | Y |
2 | Aus. Terrier | Microscopic/Metastatic | SD | 18 | Ongoing | Y |
3 | Pomeranian | Measurable | SD | 28 | Ongoing | Y |
4 | Dachshund | Measurable | PR | 61 | Ongoing | Y |
5 | Pit Bull | Metastatic | SD | 11 | Lameness | N |